Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Fixed Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.520.520.400.320.30

What is the latest Fixed Capital/Sales ratio of MANKIND PHARMA ?

The latest Fixed Capital/Sales ratio of MANKIND PHARMA is 0.52 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.52
Mar20230.52
Mar20220.40
Mar20210.32
Mar20200.30

How is Fixed Capital/Sales of MANKIND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.52
0.00
Mar2023 0.52
30.00
Mar2022 0.4
25.00
Mar2021 0.32
6.67
Mar2020 0.3 -

Other Financial Ratios of MANKIND PHARMA


Compare Fixed Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,240.6 Cr -2.1% -0.6% 33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.1%

-0.6%

33.1%

SENSEX

1.8%

-2.5%

19.9%


You may also like the below Video Courses